Recently, a systematic review and meta‐analysis regarding effect of CoQ10 on inflammatory and some oxidative stress markers on 13 RCT among coronary artery disease (CAD) patients reported that CoQ10 supplementation was associated with increased SOD and CAT levels and decreased MDA levels (Jorat et al., 2019). The gene discussed is SOD1; the disease is coronary artery disorder.